drugset / Trial / NCT00711269
Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study evaluates the efficacy and safety of SM-13496 compared with placebo in patients with schizophrenia.
Timeline
- Start
- 2008-06-27
- Primary completion
- 2010-04-27
- Completion
- 2010-04-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lurasidone | Small molecule | 40 mg | Oral |
| Subject | Lurasidone | Small molecule | 80 mg | Oral |
| Comparator | Risperidone | Other / unclassified | — | Oral |